Share on StockTwits

Bodycote PLC (LON:BOY)‘s stock had its “outperform” rating reiterated by investment analysts at Credit Suisse in a note issued to investors on Monday. They currently have a GBX 810 ($13.80) target price on the stock. Credit Suisse’s target price indicates a potential upside of 17.82% from the stock’s previous close.

Several other analysts have also recently commented on the stock. Analysts at Panmure Gordon reiterated a “buy” rating on shares of Bodycote PLC in a research note on Monday, June 2nd. They now have a GBX 877 ($14.94) price target on the stock. Separately, analysts at Numis Securities Ltd reiterated an “add” rating on shares of Bodycote PLC in a research note on Thursday, May 29th. They now have a GBX 825 ($14.05) price target on the stock. Finally, analysts at Jefferies Group reiterated a “buy” rating on shares of Bodycote PLC in a research note on Monday, May 12th. They now have a GBX 895 ($15.24) price target on the stock. Two analysts have rated the stock with a sell rating, four have issued a hold rating and eight have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of GBX 787.58 ($13.41).

Bodycote PLC (LON:BOY) opened at 693.00 on Monday. Bodycote PLC has a 1-year low of GBX 517.50 and a 1-year high of GBX 832.00. The stock’s 50-day moving average is GBX 723.1 and its 200-day moving average is GBX 720.4. The company’s market cap is £1.313 billion.

Bodycote plc (LON:BOY) is a specialized plasma spray, high velocity oxy fuel (HVOF) and thermally formed ceramic treatments.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.